[:pb]Camphor nitroimine: a key building block in unusual transformations and its applications in the synthesis of bioactive compounds[:]


Authors: Silva, E.T.; Santos, L. S.; Andrade, G. F.; Rosa, E. J. R.; De Souza, M. V. N.
Source: Molecular Diversity, v. 26, p. 3463-3483, 2022
Publisher: Springer


The development of new drugs requires a lot of time and high financial investments. It involves a research network in which there is the participation of several researchers from different areas. For a new drug to reach the market, thousands of substances must be evaluated. There are several tools for this and the use of suitable building blocks can facilitate the process by allowing a lead compound to have suitable parameters. These compounds are key structures containing special functional groups that also permit adequate synthetic transformations, leading to several structures of interest in a short period of time. In this review, the use of camphor nitroimine as a potential key building block is explored. Derived from camphor, an abundant natural product present in various plant species, this nitroimine has proved to be quite versatile, allowing the access to substances with miscellaneous biological activities, ligands to asymmetric catalysis, asymmetric oxidants, O–N transfer agents and other applications. Its easy conversion to camphecene and other derivatives is described, as well as their applications in medicinal chemistry. Druglikeness analyses were performed on these studied agents as well as on their bioactive derivatives in order to assess their use in the development of potential drugs.

Keywords: camphor, nitroimine, building block, biological activities, camphecene
Document Type: Research Article
DOI: 10.1007/s11030-021-10341-0
Publication date: 14 de Agosto de 2021[:]

Compartilhar publicação


Deixe seu comentário


Sobre a SSCDT

Nosso grupo de pesquisa está situado em Farmanguinhos e atualmente é o maior laboratório farmacêutico oficial vinculado ao Ministério da Saúde. Farmanguinhos produz mais de um bilhão de medicamentos por ano para os programas estratégicos do Governo Federal, além de atender demandas emergenciais no Brasil e no exterior.

posts Recentes